These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 17474274

  • 1. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
    Prasad SV, Ballal M, Shivananda PG.
    Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274
    [Abstract] [Full Text] [Related]

  • 2. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
    Lee YJ, Liu HY, Lin YC, Sun KL, Chun CL, Hsueh PR.
    Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
    [Abstract] [Full Text] [Related]

  • 3. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
    Gad GF, El-Domany RA, Zaki S, Ashour HM.
    J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
    [Abstract] [Full Text] [Related]

  • 4. Bacteriostatic and bactericidal activities of eight fluoroquinolones against MexAB-OprM-overproducing clinical strains of Pseudomonas aeruginosa.
    Dupont P, Hocquet D, Jeannot K, Chavanet P, Plésiat P.
    J Antimicrob Chemother; 2005 Apr; 55(4):518-22. PubMed ID: 15722391
    [Abstract] [Full Text] [Related]

  • 5. In vitro fluoroquinolone susceptibility of Pseudomonas aeruginosa isolates from dogs with ulcerative keratitis.
    Ledbetter EC, Hendricks LM, Riis RC, Scarlett JM.
    Am J Vet Res; 2007 Jun; 68(6):638-42. PubMed ID: 17542697
    [Abstract] [Full Text] [Related]

  • 6. Susceptibility testing of clinical isolates of pseudomonas aeruginosa to levofloxacin, moxifloxacin, and gatifloxacin as a guide to treating pseudomonas ocular infections.
    Epstein SP, Bottone EJ, Asbell PA.
    Eye Contact Lens; 2006 Sep; 32(5):240-4. PubMed ID: 16974157
    [Abstract] [Full Text] [Related]

  • 7. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
    Segatore B, Perilli M, Larosa M, Setacci D, Celenza G, Amicosante G.
    Int J Antimicrob Agents; 2007 Oct; 30(4):374-6. PubMed ID: 17659863
    [No Abstract] [Full Text] [Related]

  • 8. Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.
    Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.
    Diagn Microbiol Infect Dis; 2004 Sep; 50(1):43-50. PubMed ID: 15380277
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of efflux-mediated ciprofloxacin and levofloxacin resistance in recent clinical isolates of Pseudomonas aeruginosa and its reversal by the efflux pump inhibitors 1-(1-naphthylmethyl)-piperazine and phenylalanine-arginine-β-naphthylamide.
    Sonnet P, Izard D, Mullié C.
    Int J Antimicrob Agents; 2012 Jan; 39(1):77-80. PubMed ID: 21974858
    [Abstract] [Full Text] [Related]

  • 10. Report: prevalence and resistance pattern of Pseudomonas aeruginosa against various antibiotics.
    Khan JA, Iqbal Z, Rahman SU, Farzana K, Khan A.
    Pak J Pharm Sci; 2008 Jul; 21(3):311-5. PubMed ID: 18614431
    [Abstract] [Full Text] [Related]

  • 11. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa.
    Rhee MK, Kowalski RP, Romanowski EG, Mah FS, Ritterband DC, Gordon YJ.
    Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131
    [Abstract] [Full Text] [Related]

  • 12. Antibiotic susceptibility patterns of Pseudomonas aeruginosa to available antipseudomonal drugs in Ibadan, Nigeria.
    Ogbolu DO, Ogunledun A, Adebiyi OE, Daini OA, Alli AO.
    Afr J Med Med Sci; 2008 Dec; 37(4):339-44. PubMed ID: 19301711
    [Abstract] [Full Text] [Related]

  • 13. Multiple drug resistance and strength of attachment to surfaces in Pseudomonas aeruginosa isolates.
    Haddadin RN, Saleh SA, Mahmoud RA, Shehabi AA.
    Lett Appl Microbiol; 2010 Jul; 51(1):48-53. PubMed ID: 20477963
    [Abstract] [Full Text] [Related]

  • 14. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
    Macdonald D, Cuthbertson L, Doherty C, Campana S, Ravenni N, Taccetti G, Govan JR.
    J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
    [Abstract] [Full Text] [Related]

  • 15. Antimicrobial resistance and genetic characterization of fluoroquinolone resistance of Pseudomonas aeruginosa isolated from canine infections.
    Rubin J, Walker RD, Blickenstaff K, Bodeis-Jones S, Zhao S.
    Vet Microbiol; 2008 Sep 18; 131(1-2):164-72. PubMed ID: 18395369
    [Abstract] [Full Text] [Related]

  • 16. Use of pharmacokinetics and pharmacodynamics to optimize antimicrobial treatment of Pseudomonas aeruginosa infections.
    Burgess DS.
    Clin Infect Dis; 2005 Feb 15; 40 Suppl 2():S99-104. PubMed ID: 15712103
    [Abstract] [Full Text] [Related]

  • 17. Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa.
    Roveta S, Schito AM, Marchese A, Schito GC.
    Int J Antimicrob Agents; 2005 Nov 15; 26(5):366-72. PubMed ID: 16216467
    [Abstract] [Full Text] [Related]

  • 18. In vitro synergism of beta-lactams with ciprofloxacin and moxifloxacin against genetically distinct multidrug-resistant isolates of Pseudomonas aeruginosa.
    Kanellakopoulou K, Sarafis P, Galani I, Giamarellou H, Giamarellos-Bourboulis EJ.
    Int J Antimicrob Agents; 2008 Jul 15; 32(1):33-9. PubMed ID: 18538547
    [Abstract] [Full Text] [Related]

  • 19. [Low-level resistance to fluoroquinolones conferred by efflux overproduction in Pseudomonas aeruginosa: clinical significance and routine detection].
    Hocquet D, Patry I, Dupont P, Bize M, Jeannot K, Chavanet P, Plésiat P.
    Pathol Biol (Paris); 2005 Jul 15; 53(8-9):495-9. PubMed ID: 16203109
    [Abstract] [Full Text] [Related]

  • 20. [Antibiotic resistance of some Pseudomonas aeruginosa isolates].
    Matinca D, Vancea D, Boboş C, Serban O.
    Bacteriol Virusol Parazitol Epidemiol; 2003 Jul 15; 48(2-3):157-61. PubMed ID: 15341333
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.